Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-23T09:21:59.391Z Has data issue: false hasContentIssue false
  • English
  • Français

Malaria toxins: effects on murine spleen and bone marrow cell proliferation and cytokine production in vitro

Published online by Cambridge University Press:  01 November 1997

G. BORDMANN ,
N. FAVRE  and
W. RUDIN
G. BORDMANN
Affiliation:
Swiss Tropical Institute, PO Box, 4002 Basel, Switzerland
N. FAVRE
Affiliation:
Swiss Tropical Institute, PO Box, 4002 Basel, Switzerland
W. RUDIN
Affiliation:
Swiss Tropical Institute, PO Box, 4002 Basel, Switzerland
Get access Rights & Permissions [Opens in a new window]

Abstract

The ability of deproteinated malaria exoantigens from Plasmodium falciparum (Pf-MT) and P. berghei ANKA (PbA-MT) to activate murine haematopoietic cells was analysed in vitro. Malaria toxins (MT) of both plasmodium species induced cell proliferation and the production of IFN-γ in overnight and long-term (5 days) spleen and bone marrow cultures and a reduction of the number of TNF-α spot forming cells (SFC). When added to cells of malaria-experienced animals, MT decreased the number of IL-4 SPC and increased the number of IL-5 SPC. However, the same proliferative and IFN-γ induction properties as in naive cells were observed. Simultaneous addition of IL-2 and PbA-MT to spleen cells inhibited the proliferation but increased the IFN-γ production usually induced by IL-2. Flow cytometric analysis revealed that the addition of MT triggered an expansion of CD3+ and GR1+ cell populations. Our results suggest that malaria toxins of different species can induce an immediate and strong proliferation and a TH1-type cytokine release by murine cells, independently of previous in vivo priming.

Keywords

malaria toxinsPlasmodium falciparumPlasmodium berghei ANKAmurine haematopoiesisimmunity
Type
Research Article
Information
Parasitology , Volume 115 , Issue 5 , November 1997 , pp. 475 - 483
Copyright
1997 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)